Case Details
- Citation: [2023] SGHC 23
- Title: Tritech Water Technologies Pte Ltd and others v Duan Wei and another
- Court: High Court of the Republic of Singapore (General Division)
- Suit No: Suit No 941 of 2018
- Date of Judgment: 22 February 2023
- Judge: Valerie Thean J
- Hearing Dates: 29, 30 September, 4–7, 11–13, 18–21 October, 2 December 2022
- Plaintiffs/Applicants: Tritech Water Technologies Pte Ltd; Tritech Environmental Group Co Ltd; Tritech Engineering & Testing (Singapore) Pte Ltd
- Defendants/Respondents: Duan Wei; Luo Zhuobiao
- Legal Areas: Tort — Misrepresentation; Tort — Negligent misrepresentation; Tort — Negligence; Intellectual Property — Law of confidence
- Core Claims (as reflected in the judgment structure): Breach of confidence; fraudulent misrepresentation; negligent misrepresentation; negligence; breach of duty of good faith and fidelity; breach of fiduciary duty; contractual duty to exercise reasonable skill and care; unlawful means conspiracy
- Key Factual Themes: Alleged misuse of confidential information by a former employee; alleged misrepresentations and/or lack of reasonable care by a former technical expert; alleged rapid production capability inconsistent with claimed expertise; trap purchase and subsequent PRC proceedings
- Procedural/Remedial Context: Court preservation proceedings on Dreamem’s premises; summary dismissal for misconduct; parallel litigation in the PRC
- Statutes/Limitations Referenced (as per metadata provided): The claim relating to the “FO Production Line” is argued to be barred by the Limitation Act
- Cases Cited (as per metadata provided): [1991] SGHC 27; [2021] SGHC 246; [2023] SGHC 23
- Judgment Length: 71 pages; 19,485 words
Summary
In Tritech Water Technologies Pte Ltd and others v Duan Wei and another [2023] SGHC 23, the High Court (Valerie Thean J) dealt with a multi-pronged dispute arising from the departure of two former employees who had been integral to Tritech’s China operations. The plaintiffs, part of the Tritech Group, alleged that the defendants misused confidential information and engaged in various forms of wrongdoing, including misrepresentation and breach of duties owed to their employer. The case is notable for its structured analysis across several distinct subject matters: the “FO Production Line”, “Mr Machines”, and the “RO Production Line”, as well as separate equitable and contractual claims.
The judgment addressed (i) whether there were actionable misrepresentations by Dr Duan (including whether any such misrepresentations were fraudulent), (ii) whether Dr Duan failed to exercise reasonable care and skill in the performance of his duties, (iii) whether the defendants breached duties of good faith and fidelity and/or fiduciary obligations, and (iv) whether confidential information was imparted in circumstances of confidence and then misused. The court also considered reliance and loss, and the equitable framework for breach of confidence, including the requirement of a “necessary quality of confidence”.
Ultimately, the court’s decision turned on careful findings of fact about what was represented, what was known at the relevant time, and whether the plaintiffs could prove the elements of each tort and equitable claim. The judgment also illustrates how limitation arguments may affect discrete heads of claim, particularly where the alleged wrongdoing relates to specific projects and time periods.
What Were the Facts of This Case?
Tritech Group Limited (“TGL”) is an engineering services provider listed on the Singapore Stock Exchange, with two principal businesses: urban infrastructure and water and environmental technology. The three plaintiffs were subsidiaries of TGL. The first plaintiff, Tritech Water Technologies Pte Ltd (“TWT”), is incorporated in Singapore and supplies water and environmental solutions, specialising in membranes and membrane-related products and services. It also serves as the R&D centre for water treatment and environmental technologies within the group. The second plaintiff, Tritech Environmental Group Co Ltd (“TEG”), is incorporated in the People’s Republic of China and provides water treatment solutions. The third plaintiff, Tritech Engineering & Testing (Singapore) Pte Ltd (“TET”), is incorporated in Singapore and provides geotechnical instrumentation monitoring and site investigation services.
The defendants were former employees who had been integral to Tritech’s China operations. Dr Duan Wei (“Dr Duan”) was employed by TWT from 1 August 2011, initially as a “Principal Engineer”, and later became Chief Technical Officer of TWT and the Water & Environment Group of Tritech’s companies. He resigned on 12 March 2017 and left employment on 31 March 2017. Mr Luo Zhuobiao (“Mr Luo”) was employed by TET as an engineer from 3 November 2006. His employment was transferred from TET to TWT in September 2011. From 2012 onwards, he held a series of key positions, and by 2018 he was Chief Commercial Officer and Chief Supervisor of network marketing promotion at TEG.
The plaintiffs’ case had two broad parts. First, Tritech brought a claim for breach of confidence against the defendants. Near the end of 2017, Tritech staff observed Mr Luo taking an undue interest in operations outside his scope of work. Rumours circulated that Mr Luo and Dr Duan—who had left by then—were working together. Dr Wang Xiaoning (TGL’s managing director and CEO) was informed at the beginning of 2018. Tritech then discovered that Dr Duan had incorporated another company, Dreamem, on 1 March 2017, before he resigned from Tritech. In June 2018, Tritech conducted a “trap purchase” of Dreamem’s products, with Mr Luo representing Dreamem. Tritech obtained products alleged to be identical or substantially similar to Tritech’s. Tritech subsequently commenced proceedings in the PRC, and preservation steps were taken at Dreamem’s premises on 31 August 2018. Mr Luo was summarily dismissed for misconduct on the same day.
Second, Tritech’s claims against Dr Duan expanded beyond breach of confidence. Based on facts that emerged during investigations into the breach of confidence allegations, Tritech advanced claims in breach of fiduciary duty, fraudulent misrepresentation, negligent misrepresentation, and breach of Dr Duan’s implied contractual duty to exercise reasonable skill and care in performing his duties. The judgment’s organisation reflects that these claims were tied to specific technical projects and equipment—namely the “FO Production Line”, “Mr Machines”, and the “RO Production Line”.
What Were the Key Legal Issues?
The first set of issues concerned misrepresentation and negligence in relation to Dr Duan’s technical involvement in Tritech’s membrane-related projects. The court had to determine, for each relevant project/equipment set, whether Dr Duan made an actionable misrepresentation, whether any misrepresentation was fraudulent, and whether Dr Duan failed to exercise reasonable care and skill in performing his duties. These issues were framed separately for the “FO Production Line” and “Mr Machines”, and then for the “RO Production Line”.
The second set of issues concerned reliance and loss. Even if misrepresentations were established, Tritech needed to show that it relied on them (or that reliance was otherwise legally relevant) and that the reliance caused loss. This required the court to examine the causal link between the alleged misstatements and the plaintiffs’ damages, including how the technical procurement and production processes unfolded.
The third set of issues concerned the equitable claim for breach of confidence. The court had to consider whether the information at issue had the necessary quality of confidence, whether it was imparted in circumstances of confidence, and whether it was misused by the defendants. This equitable framework also required the court to consider wrongful gain and wrongful loss, and to assess the evidence of similarity between Tritech’s products and Dreamem’s products, including the timing of Dreamem’s production and the defendants’ access to Tritech’s knowledge.
How Did the Court Analyse the Issues?
The court began by setting out the technical and organisational context. Tritech’s membrane-related technology involved different categories of membranes, including hollow fibre membranes and flat sheet membranes. The flat sheet membranes were used for nanofiltration, forward osmosis (“FO”), and reverse osmosis (“RO”), and they were fabricated using different production processes and equipment. Tritech’s R&D initially focused on hollow fibre membranes, but flat sheet membrane work began in 2010 through a collaboration between Dr Wang and Associate Professor Ng How Yong at the National University of Singapore (“NUS”). The collaboration used laboratory settings to determine fabrication methods and processes for flat sheet membranes suitable for FO.
Dr Duan’s role was central to the FO Project. As part of the plan to set up a commercial production line for FO membranes, Dr Wang invited Dr Duan to lead the Tritech team. An agreement was reached allowing Dr Duan to complete his work with the NUS-Tritech collaboration before joining TWT as an employee. Tritech paid him an allowance during the interim period, and an exclusive licence agreement was entered into with NUS regarding the formula used within NUS for the planned commercial production line. This background mattered because it shaped what knowledge Dr Duan had, what he was tasked to do, and what representations he could reasonably be expected to make in the course of vendor selection, design commissioning, and pre-delivery inspections.
For the “FO Production Line”, the court’s analysis focused on whether Dr Duan made actionable misrepresentations. The judgment structure indicates that the court asked: “Was there an actionable misrepresentation by Dr Duan?” and then, separately, “Was there a failure to exercise reasonable care and skill in the performance of his duties?” The court also dealt with whether the misrepresentations were fraudulent, and it addressed reliance and loss. In practical terms, this meant the court scrutinised communications and conduct during the procurement and inspection stages—such as Dr Duan’s involvement in vendor selection visits, his responses about suppliers’ capabilities, and his reports to Dr Wang about testing limitations and constraints.
For example, during pre-delivery inspections at Shanghai Dahe’s premises in February 2012 and May 2012, Dr Duan notified Dr Wang by email that he had not been able to test the full production line because the workshop was too small and the production line could not be fully extended, and that plumbing and wiring needed to be cut and installed according to Tritech’s plant conditions. The judgment’s approach suggests that the court assessed whether such statements were accurate, whether they were misleading by omission, and whether they amounted to misrepresentations in law. It also considered whether Dr Duan’s conduct met the standard of reasonable skill and care expected of him, given his technical expertise and his role in leading the project.
For “Mr Machines” and the “RO Production Line”, the court followed a similar analytical pattern. It asked whether there were actionable misrepresentations by Dr Duan, and for the “RO Production Line” it also asked whether the misrepresentations were fraudulent. The court’s reasoning reflects the doctrinal distinctions between fraudulent misrepresentation (requiring proof of dishonesty or intent to induce) and negligent misrepresentation (requiring a duty of care and breach, with causation and reliance). The judgment also indicates that the court treated the issues of reliance and loss as a separate and necessary step, rather than assuming that proof of misrepresentation automatically established damages.
On the equitable claim for breach of confidence, the court applied the established principles: confidential information must have the necessary quality of confidence; it must be imparted in circumstances importing an obligation of confidence; and there must be misuse. The judgment’s structure shows that the court examined whether Dreamem produced products identical or substantially similar to Tritech’s, whether Dreamem could produce these membranes within a very short period despite lacking the requisite expertise, and whether the timing of Mr Luo’s taking of confidential information coincided with Dreamem’s commencement of production. These factors were used to infer misuse and to connect access to information with subsequent competitive activity.
The court also addressed the consequences of breach in equitable terms, including wrongful gain and wrongful loss. This required the court to consider what Tritech lost (for example, competitive advantage, exclusivity, or the value of its know-how) and what Dreamem gained by using Tritech’s confidential information. The judgment further indicates that Tritech advanced additional claims in equity and contractual claims, as well as an unlawful means conspiracy theory. While the detailed findings are not fully reproduced in the extract provided, the organisation of the judgment suggests that the court treated these as alternative or complementary routes to relief, depending on which elements were proven on the evidence.
What Was the Outcome?
The extract provided does not include the final dispositive orders. However, the judgment’s detailed structure—covering misrepresentation, negligence, breach of confidence, reliance and loss, and equitable remedies—indicates that the court made findings on each pleaded cause of action. In cases of this type, the outcome typically depends on whether the plaintiffs proved the elements of each claim to the required standard, particularly for fraudulent misrepresentation and for breach of confidence, where the court must be satisfied as to the existence and misuse of confidential information.
Practically, the outcome would determine whether Tritech obtained damages (or other monetary relief) against Dr Duan and/or Mr Luo, and whether injunctive or equitable remedies were granted. The court’s analysis of limitation arguments (as reflected in the metadata) also suggests that some claims or heads of loss could have been time-barred, affecting the extent of recoverable damages even if liability was otherwise established.
Why Does This Case Matter?
This case is significant for practitioners because it demonstrates how Singapore courts approach complex employment-adjacent disputes that combine tort, contract, fiduciary/equitable duties, and intellectual property concepts of confidence. The judgment shows that courts will not treat “misconduct” as a single umbrella label; instead, they will require proof of distinct legal elements for each cause of action, including the mental element for fraud and the evidential link between confidential information and subsequent competitive conduct.
For lawyers advising employers or technology companies, the case underscores the evidential importance of documenting access to information, the circumstances in which information was imparted, and the timing of alleged misuse. The court’s focus on the “necessary quality of confidence” and on the coincidence between access and production highlights how circumstantial evidence (such as rapid production capability and product similarity) can be relevant, but must still be anchored to the legal requirements of confidence.
For defendants and counsel, the case illustrates the need to challenge each element: whether statements were actually made, whether they were misleading, whether reliance was established, and whether the standard of care was breached. The structured approach to “FO Production Line”, “Mr Machines”, and “RO Production Line” also indicates that courts may treat different projects separately, including for limitation purposes, thereby affecting liability and damages in a granular way.
Legislation Referenced
- Limitation Act (as referenced in the metadata: argument that the claim relating to the “FO Production Line” is barred by the Limitation Act)
Cases Cited
- [1991] SGHC 27
- [2021] SGHC 246
- [2023] SGHC 23
Source Documents
This article analyses [2023] SGHC 23 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.